Novel promiscuous HLA-DQ HIV Nef peptide that induces IFN-γ-producing memory CD4+ T cells

Clinical and Experimental Immunology

Volumn 129, Issue 3, 2002, Pages 429-437

  Pancre V ^a   Georges, B ^a,b   Angyalosi, G ^a,b   Castelli, F ^c   Delanoye, A ^a   Delacre, M ^a   Hachulla, E ^d   Maillere, B ^c   Bouzidi, A ^b  

^a UMR 8527   (France)

^b Institut de Biologie   (France)

^c CEA SACLAY   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Epitope; HLA transgenic mice; Human; T cell receptor; Th1 cells

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; HLA DQ ANTIGEN; HLA DR ANTIGEN; NEF PROTEIN; PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; GENOTYPE; HEALTH STATUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; MEMORY CELL; MOUSE; NONHUMAN; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; T LYMPHOCYTE; TRANSGENIC MOUSE;

ALLELES; AMINO ACID SEQUENCE; ANIMALS; CELLS, CULTURED; CLONE CELLS; CONSERVED SEQUENCE; GENE PRODUCTS, NEF; HISTOCOMPATIBILITY ANTIGENS CLASS II; HIV; HLA-DQ ANTIGENS; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; MICE; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL; TH1 CELLS;

EID: 18544390924     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.01934.x     Document Type: Article

References (42)

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
2. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
3. Identification of a reservoir for HIV-1 in patients on highly active anti-retroviral therapy
4. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
5. + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
6. Early and persistent human immunodeficiency virus type 1 (HIV-1) -specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection
7. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable non-progressing HIV type 1 infection
8. + T cell responses associated with control of viremia
9. HIV pathogenesis and long term survival
10. Universally immunogenic T cell epitopes: Promiscuous binding to human MHC class II and promiscuous recognition by T cells
11. Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides
12. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: Identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein
13. Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and human of multiple MHC types
14. + T cells by at least four unrelated HLA-DR molecules
15. Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T lymphocyte epitopes
16. T helper cell epitopes of the human immunodeficiency virus (HIV-1) nef protein in rats and chimpanzees
17. Determination of B-cell epitopes of nef HIV-1 protein: Immunogenicity related to their structure
18. Frmoc solid phase peptide synthesis
19. Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line
20. HLA-DR restricted peptide candidates for bee venom immunotherapy
21. HLA transgenic mice as humanized mouse models of disease and immunity
22. An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen
23. Mice lacking MHC class II molecules
24. Schistosomal egg antigen-responsive CD8 T cell population in Schistosoma mansoni-infected BALB/c mice
25. + peripheral blood monocytes
26. Generation and cloning of antigen-specific human T cells
27. An experimentally validated panel of subfamily-specific oligonucleotide primers (Vα1-w29/Vβ1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction
28. On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs
29. Promiscuous and allele-specific anchors in HLA-DR binding peptides
30. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices
31. Naturally processed peptides from HLA-DQ7 (alpha1*0501-beta1*0301). Influence of both alpha and beta chain polymorphism in the HLA-DQ peptide binding specificity
32. Identification of a putative motif for binding of peptides to HLA-DQ2
33. Reciprocal control of T helper cell and dendritic cell differentiation
34. Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction
35. The concept of type 1 and type 2 antigen-presenting cells
36. Dynamics of T lymphocyte responses: Intermediates, effectors and memory cells
37. Preferential Vβ usage and lack of junctional sequence conservation among human T cell receptors specific for a tetanus toxin-derived peptide: Evidence for a dominant role of germline-encoded V region in antigen/major histocompatibility complex recognition
38. Degeneracy of T cell receptor recognition of an influenza virus hemagglutinin epitope restricted by HLA-DQ and - DR class II molecules
39. Conserved TCR beta chain usage for a single MHC class II-restricted heat shock protein peptide
40. Biased T-cell receptor usage is associated with allelic variation in the MHC class II peptide binding groove
41. Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens
42. Type 1 cytokine production and low prevalence of viral isolation correlate with long-term nonprogression in HIV-infection